Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2018 May 15:9:980.
doi: 10.3389/fmicb.2018.00980. eCollection 2018.

Oropharyngeal Candidosis in HIV-Infected Patients-An Update

Shankargouda Patil  1 , Barnali Majumdar  2 , Sachin C Sarode  3 , Gargi S Sarode  3 , Kamran H Awan  4
Affiliations
Review

Oropharyngeal Candidosis in HIV-Infected Patients-An Update

Shankargouda Patil et al. Front Microbiol. .

Abstract

Oropharyngeal candidosis (OPC) is an opportunistic fungal infection that is commonly found in HIV-infected patients, even in the twenty-first century. Candida albicans is the main pathogen, but other Candida species have been isolated. OPC usually presents months or years before other severe opportunistic infections and may indicate the presence or progression of HIV disease. The concept of OPC as a biofilm infection has changed our understanding of its pathobiology. Various anti-fungal agents (both topical and systemic) are available to treat OPC. However, anti-fungal resistance as a result of the long-term use of anti-fungal agents and recurrent oropharyngeal infection in AIDS patients require alternative anti-fungal therapies. In addition, both identifying the causative Candida species and conducting anti-fungal vulnerability testing can improve a clinician's ability to prescribe effective anti-fungal agents. The present review focuses on the current findings and therapeutic challenges for HIV-infected patients with OPC.

Keywords: AIDS; Candida; HIV; Oropharyngeal candidosis; antifungals; opportunistic infections.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Diagnostic protocol for oropharyngeal candidiasis in HIV-positive patients.
See this image and copyright information in PMC

References

    1. Achenbach C. J., Harrington R. D., Dhanireddy S., Crane H. M., Casper C., Kitahata M. M. (2011). Paradoxical immune reconstitution inflammatory syndrome in HIV-infected patients treated with combination antiretroviral therapy after AIDS-defining opportunistic infection. Clin. Infect. Dis. 54, 424–433. 10.1093/cid/cir802 - DOI - PMC - PubMed
    1. Adedigba M. A., Ogunbodede E. O., Jeboda S. O., Naidoo S. (2008). Patterns of oral manifestation of HIV/AIDS among 225 Nigerian patients. Oral Dis. 14, 341–346. 10.1111/j.1601-0825.2007.01384.x - DOI - PubMed
    1. Alves C. T., Wei X. Q., Silva S., Azeredo J., Henriques M., Williams D. W. (2014). Candida albicans promotes invasion and colonisation of Candida glabrata in a reconstituted human vaginal epithelium. J. Infect. 69, 396–407. 10.1016/j.jinf.2014.06.002 - DOI - PubMed
    1. Panomvana Na Ayudhya D., Thanompuangseree N., Tansuphaswadikul S. (2004). Effect of rifampicin on the pharmacokinetics of fluconazole in patients with AIDS. Clin. Pharmacokinet. 43, 725–732. 10.2165/00003088-200443110-00003 - DOI - PubMed
    1. Barros P. P., Ribeiro F. C., Rossoni R. D., Junqueira J. C., Jorge A. O. C. (2016). Influence of Candida krusei and Candida glabrata on Candida albicans gene expression in in vitro biofilms. Arch. Oral Biol. 64, 92–101. 10.1016/j.archoralbio.2016.01.005 - DOI - PubMed

LinkOut - more resources